1. Guest, the 'News in Brief' for the week beginning 12th July 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice
  3. Contribute to feedback on the CDC Evidence Review, for more details click here
    Dismiss Notice

Virios Therapeutics - biotech company with anti-viral therapies for post-infection syndromes

Discussion in 'BioMedical ME/CFS News' started by Sly Saint, May 8, 2021.

  1. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    6,249
    Likes Received:
    51,299
    Location:
    UK
    https://www.pharmiweb.com/press-rel...t-at-the-benzinga-global-small-cap-conference
     
    MEMarge, sebaaa, Hutan and 2 others like this.
  2. Mij

    Mij Senior Member (Voting Rights)

    Messages:
    4,819
    Likes Received:
    25,305
    Virios currently holds 20 patents that include composition of matter, a unique synergy patent and method of use patents for FM, IBS & CFS patents. as well as Functional Somatic Syndrome (recently renamed the Somatic Symptom Disorder (SSD). These additional chronic conditions represent a substantially larger market opportunity. The below listed SSD conditions are all chronic-pain related conditions. Based on blinded survey data, we believe that many of the SSD conditions will be responsive to treatment with IMC-1.
    https://www.virios.com/pipeline

    1. Fibromyalgia

    2. Irritable Bowel Syndrome

    3. Chronic Pelvic Pain

    4. Chronic Neck and Back Pain

    5. Temporomandibular Joint Dysfunction (TMJ)

    6. Frequent Headaches
     
    sebaaa, Hutan and DokaGirl like this.
  3. voner

    voner Senior Member (Voting Rights)

    Messages:
    100
    Likes Received:
    619
    This is the company begun from Skip Pridgen's protocols. He is on the board of Directors:

    William L. Pridgen, M.D
    William L. Pridgen, M.D. is our founder and has been a director since 2018. Dr. Pridgen is a board-certified surgeon practicing with Tuscaloosa Surgical Associates, P.C. in Tuscaloosa, Alabama. Dr. Pridgen obtained his B.S. in Biology from Rhodes College, attending the medical school and completing his surgical residency at the University of Tennessee College of Medicine. Dr. Pridgen is certified in general surgery and is a fellow of the American College of Surgeons. Dr. Pridgen has spent nearly 20 years searching for effective treatments in IBS, FM, and MECFS, and served as a physician and surgeon in the United States Navy for five years.
     
  4. cfsandmore

    cfsandmore Established Member (Voting Rights)

    Messages:
    73
    Likes Received:
    434
    Location:
    USA
    Are they (Skip Pridgen) the team doing the Phase 2B trial?

    edit: added Skip Pridgen
     
  5. Wonko

    Wonko Senior Member (Voting Rights)

    Messages:
    4,987
    Likes Received:
    38,004
    Location:
    UK
    How could Somatic Symptom Disorder possibly be successfully and/or ethically be treated using antivirals - given that the definition excludes any biological cause for symptoms?

    Or, is it just a case of lets make some money from the sickies (doesn't matter if it's ethical or might work)?

    (I am aware that most, if not all, people diagnosed with SSD probably have a biological reason for their symptoms, just not ones that a GP or his favourite psychiatrist can be bothered to look for. It just puzzles me how people who have decided that there can be no biomedical explanation, who then diagnose SSD, can then be happy to offer antivirals - to the same patients).

    Is this another have cake, eat it, and then still have all the cake scenario?
     
    Last edited: May 13, 2021
  6. voner

    voner Senior Member (Voting Rights)

    Messages:
    100
    Likes Received:
    619
    cfsandmore likes this.

Share This Page